US Patent

US11464752 — Compositions comprising ephedrine or an ephedrine salt and methods of making and using same

Formulation · Assigned to Nexus Pharmaceuticals Inc · Expires 2040-05-16 · 14y remaining

Vulnerability score 50/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects compositions of ephedrine sulfate ready for immediate use in a clinical setting and methods for making and using them.

USPTO Abstract

The present disclosure provides compositions comprising ephedrine sulfate ready for immediate use in a clinical setting, and methods of making and using same.

Drugs covered by this patent

ephedrine-sulfate (EPHEDRINE SULFATE)

Patent Metadata

Patent number: US11464752
Jurisdiction: US
Classification: Formulation
Expires: 2040-05-16
Drug substance claim: No
Drug product claim: Yes
Assignee: Nexus Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.